8-KMaterial AgreementsOther Events

CME GROUP INC. 8-K Report, Material Agreement (Jul 6, 2007)

Filed July 6, 2007For Securities:CME

Summary

This 8-K filing from CME Group Inc. (CME) on July 6, 2007, details a significant amendment to its merger agreement with CBOT Holdings, Inc. (CBOT). Specifically, Amendment No. 4 to the Agreement and Plan of Merger modifies the exchange ratio for the transaction. Investors should note that the amended terms stipulate that for each share of CBOT Holdings Class A common stock, CBOT stockholders will now receive 0.3750 shares of CME Holdings Class A common stock. This adjustment to the merger consideration is a key development that will impact the ultimate value received by CBOT shareholders and the pro forma ownership structure of the combined entity. The filing also includes a joint press release from CME and CBOT announcing this amendment.

Key Highlights

  • 1CME Group Inc. (CME) filed an 8-K on July 6, 2007, related to its merger with CBOT Holdings, Inc. (CBOT).
  • 2The filing announces Amendment No. 4 to the existing Agreement and Plan of Merger.
  • 3The primary change involves the exchange ratio for the merger.
  • 4CBOT Holdings Class A stockholders will receive 0.3750 shares of CME Holdings Class A common stock per share of CBOT Holdings Class A common stock.
  • 5This amendment revises previously agreed-upon terms for the merger consideration.
  • 6A joint press release from CME and CBOT was issued on July 6, 2007, to announce this amendment.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce and detail Amendment No. 4 to the Agreement and Plan of Merger between CME Group Inc. (CME) and CBOT Holdings, Inc. (CBOT), specifically modifying the stock exchange ratio for the merger.

Under Amendment No. 4, for each share of CBOT Holdings Class A common stock, CBOT stockholders will now receive 0.3750 shares of CME Holdings Class A common stock.

This amendment is important as it changes the terms of the merger, impacting the number of CME shares that will be issued to CBOT shareholders. This affects CME's future ownership structure, dilution, and the ultimate cost of the acquisition. Investors should assess how this new exchange ratio impacts the strategic and financial rationale of the merger.

The filing also notes that a joint press release was issued by CME and CBOT on the same day to publicly announce this amendment to the merger agreement. This press release would likely provide further context and commentary on the changes.